Dow Down0.17% Nasdaq Down0.28%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.19 Down 0.06(1.41%) 4:15PM EDT
|After Hours : 4.15 Down 0.04 (0.95%) 4:49PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 81,394   27,587   12,719  
Cost of Revenue6,180  3,671  8,100  
Gross Profit 75,214   23,916   4,619  
Operating Expenses
Research Development66,468  54,112  58,706  
Selling General and Administrative31,681  26,226  24,248  
Non Recurring -   -  3,467  
Others -  691  997  
Total Operating Expenses -   -  87,418  
Operating Income or Loss (22,935) (57,113) (82,799)
Income from Continuing Operations
Total Other Income/Expenses Net10,591  (19,244)(12,116)
Earnings Before Interest And Taxes(12,344)(70,019)(84,401)
Interest Expense7,091  9,120  14,309  
Income Before Tax(19,435)(79,139)(98,710)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(19,435)(85,477)(109,224)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (19,435) (85,477) (109,224)
Preferred Stock And Other Adjustments -  (2,824)(2,260)
Net Income Applicable To Common Shares (19,435) (88,301) (111,484)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.